Showcase: RIF Robotics Corp

April 23, 2025 8:55–9:15 AM
Strategy 2

At RIF Robotics, we are building PacR, a product that leverages computer vision, artificial intelligence, and robotics to streamline the inspection of surgical instruments for cleanliness and automate surgical tray assembly in hospitals and ambulatory surgery centers to eliminate surgery delays and improve patient outcomes.

Alex Kopelyan

Image of Alex Kopelyan, Senior Director and Partner at SOSV

As Senior Director and Partner at IndieBio, Alex is responsible for managing all of the day-to-day operations associated with the program, demo day, and the alumni network. He works closely with teams during the program on customer discovery and sales, and with investors, press, and partners to build and sustain the IndieBio ecosystem.

Showcase: Parasight System Inc

April 23, 2025 10:10–10:30 AM
Strategy 1

Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for a variety of diagnostic tests and different medium, including fecal, heartworm, and Lyme disease tests in veterinary practices.

Showcase: Moleculera Biosciences, Inc.

April 23, 2025 9:45–10:05 AM
Strategy 1
Sectors
Session Type

Moleculera Biosciences is pioneering the diagnosis, treatment, and monitoring of immune-related neuropsychiatric, cardiovascular, Long-COVID, and neurodegenerative disorders. The complexity of immune-mediated chronic conditions has placed an enormous burden on the healthcare system, which is at the core of the future of human health. We enable clinicians with technologies needed to accurately diagnose, treat, and monitor patients suffering from certain chronic debilitating disorders to experience remarkable recoveries.

Showcase: VivoSphere LLC

April 23, 2025 9:20–9:40 AM
Strategy 1

Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for a variety of diagnostic tests and different medium, including fecal, heartworm, and Lyme disease tests in veterinary practices.

Jennifer T Caldwell

Image of Jennifer T Caldwell, Director, Technology Transfer

Jennifer Caldwell is Director of Technology Transfer. Previously, Caldwell led the Technology Commercialization Group in the Partnerships Office at ORNL, which is operated and managed by UT-Battelle, LLC.  She manages the Technology Commercialization Group which is responsible for intellectual property portfolio management, licensing, and technology transfer.  Caldwell works closely with businesses in our community and nation-wide to bring emerging technologies from research institutions to the marketplace.